Future perspectives for pharmacy on atrial fibrillation

Atrial fibrillation (AF) remains a prevalent and, if left undiscovered and/or untreated, a dangerous long term disorder. Many programmes across the UK have over the years attempted to address the often silent problem that is AF.

These schemes have sought to detect, protect and perfect the management of this disorder in attempts to prevent often catastrophic AF related strokes.

We were therefore very proud to welcome Lis to share her expertise on atrial fibrillation now and into the future.

Lis Neubeck is Professor of Cardiovascular Health in the School of Health and Social Care at Edinburgh Napier University. She is the Head of the Centre for Cardiovascular Health Research at Edinburgh Napier University. Lis has recently taken up the role of National Health Service Research Scotland Cardiovascular Clinical Network Lead.

Please read our CPD disclaimer before enrolling.

Course Information

Estimated Time: 45minutes

Difficulty: Advanced

Categories:

Course Instructor

PIP editor PIP editor Author

A pharmacist led training provider.

Click here to enroll

FREE

Register

A strong password is required with at least 8 characters. To make it stronger, use both upper and lower case letters, numbers, and symbols.
How do you want your name displayed on the site?
If we don't have your profession listed, let us know here.
If you enter your professional registration number here, we can add it to your certificates for your CPD

Privacy policy statement.

We will use your email address to facilitate the features of this course and others you enrol on with Pharmacy in Practice. Communications to your email may include important clinical updates, reminders to complete the course, delivery of quiz results and also delivery of your certificates. Please tick the box to let us know that you agree with these terms.

Introduction

Future perspectives for pharmacy on atrial fibrillation

Feedback and post course reflective revalidation entry

Leave a Reply

Your email address will not be published.